PRISM Mid-Day Movers: Psychedelics and Pet Care are Today’s Index Leaders.

Psyence Biomedical (NASDAQ: PBM) is surging today as its 1‑for‑6.25 reverse stock split takes effect, propelling the nominal share price sharply higher on heavy volume as the float contracts. Shares are trading around 9.50–9.60 dollars intraday, up dramatically from sub‑1‑dollar levels before consolidation, with roughly 700 thousand shares changing hands as liquidity recalibrates post‑split. The move follows Nasdaq corporate actions confirming that PBM would begin trading on a post‑consolidated basis at today’s open, leaving just over 1 million common shares outstanding versus more than 6 million pre‑split. Price action reflects a mechanical re-pricing rather than purely fundamental news, but it does coincide with the company’s 2026 capital strategy, including a board‑authorized share buyback framework that may be supporting sentiment in this high‑beta psychedelic therapeutics name.

 

Dogness International Corporation (NASDAQ: DOGZ) is having a very strong session today, with the stock up about 27.6% to 1.34 dollars, on unusually heavy trading volume of roughly 20,490 shares versus an average of about 672 shares. Despite today’s sharp rebound, the name remains deeply depressed relative to its early‑2026 level, down about 87.4% from a price of 10.60 dollars on January 2, 2026, leaving the market capitalization near 18 million dollars. The outsized percentage move on low absolute volume suggests traders are reacting to the thin float and prior severe drawdown, amplifying intraday volatility rather than signaling a clear fundamental re‑rating in this small‑cap pet “smart ecosystem” play.

 

 Other Notable Movers:

Ascent Solar Technologies, Inc. (ASTI) up 22%

Perspective Therapeutics (CATX) up 21%

Battalion Oil Corporation (BATL) down -20%

Share this article:

About the Author:

Archer Signs Multiyear Formula 1 Partnership to Explore Air Taxi Services at Grand Prix Events

Alex Corbit

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup